Immunogenicity and safety of fully liquid DTaP5-IPV-Hib compared with DTaP3-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: A phase III, single-blind, randomised, controlled, multicentre study
2006 ◽
Vol 105
(7)
◽
pp. 542-549
◽
2015 ◽
Vol 12
(2)
◽
pp. 293-300
◽
2004 ◽
Vol 23
(6)
◽
pp. 485-489
◽